Generation of data on within-subject biological variation in laboratory medicine: An update

Critical Reviews in Clinical Laboratory Sciences

Volumn 53, Issue 5, 2016, Pages 313-325

  Braga, Federica ^a   Panteghini, Mauro ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

analytical goals; between subject biological variation; index of individuality; inter individual biological variation; Intra individual biological variation; normality test; reference change value; within subject biological variation

Indexed keywords

ANALYTIC METHOD; CHECKLIST; HUMAN; LABORATORY; MEDICINE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; REFERENCE VALUE; REVIEW; SCIENTIST; SENSITIVITY ANALYSIS; BIOLOGICAL VARIATION; DIAGNOSTIC PROCEDURE; REPRODUCIBILITY; STANDARDS;

BIOLOGICAL VARIATION, POPULATION; DIAGNOSTIC TECHNIQUES AND PROCEDURES; HUMANS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 84961202240     PISSN: 10408363     EISSN: 1549781X     Source Type: Journal    
DOI: 10.3109/10408363.2016.1150252     Document Type: Review

References (82)

1. C.G.Fraser Biological Variation: from Principles to Practice. Washington (DC): AACC Press, 2001: 9–18
2. C.G.Fraser, E.K.Harris Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989;27:409–37
3. F.Braga, M.Panteghini Verification of in vitro medical diagnostics (IVD) metrological traceability: responsibilities and strategies. Clin Chim Acta 2014;432:55–61
4. C.G.Fraser, A.Kallner, D.Kenny,. Strategies to set global analytical quality specifications in laboratory medicine. Scand J Clin Lab Invest 1999;59:475–585
5. M.Panteghini, S.Sandberg Defining analytical performance specifications 15 years after the Stockholm conference. Clin Chem Lab Med 2015;53:829–32
6. S.Sandberg, C.Fraser, A.R.Horvath,. Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem Lab Med 2015;53:833–5
7. G.G.Klee Establishment of outcome-related analytic performance goals. Clin Chem 2010;56:714–22
8. C.G.Fraser, P.Hyltoft Peterson, J.C.Libeer,. Proposal for setting generally applicable quality goals solely based on biology. Ann Clin Biochem 1997;34:8–12
9. W.P.Oosterhuis Gross overestimation of total allowable error based on biological variation. Clin Chem 2011;57:1334–6
10. Desirable Biological Variation Database Specifications. Available from: www.westgard.com/biodatabase1.htm [last accessed 14 Jan 2016]
11. C.G.Fraser, P.Hyltoft Peterson, M.L.Larsen Setting analytical goals for random analytical error in specific clinical monitoring situations. Clin Chem 1990;36:1625–8
12. G.L.Horowitz, S.Altaie, J.C.Boyd,. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline – third edition CLSI document C28-A3. Wayne, PA: Clinical and Laboratory Standards Institute, 2008
13. E.K.Harris Statistical aspect of reference values in clinical pathology. Prog Clin Pathol 1981;8:45–66
14. C.G.Fraser Making better use of differences in serial laboratory results. Ann Clin Biochem 2012;49:1–3
15. C.G.Fraser Reference change values. Clin Chem Lab Med 2012;50:807–12
16. E.K.Harris, T.Yasaka On the calculation of a “reference change” for comparing two consecutive measurements. Clin Chem 1983;29:25–30
17. F.Ceriotti, R.Hinzmann, M.Panteghini Reference intervals: the way forward. Ann Clin Biochem 2009;46:8–17
18. F.Braga, S.Ferraro, D.Szöke,. Estimate of intraindividual variability of C-reactive protein: a challenging issue. Clin Chim Acta 2013;419:85–6
19. F.Braga, S.Ferraro, F.Ieva,. A new robust statistical model for interpretation of differences in serial test results from an individual. Clin Chem Lab Med 2015;53:815–22
20. W.G.Miller, D.E.Bruns, G.L.Hortin,. Current issues in measurement and reporting of urinary albumin excretion. Clin Chem 2009;55:24–38
21. F.Braga, A.Dolci, A.Mosca,. Biological variation of glycated hemoglobin. Clin Chim Acta 2010;411:1006–10
22. F.Braga, M.Panteghini Biologic variability of C-reactive protein: is the available information reliable? Clin Chim Acta 2012;413:1179–83
23. A.Carobene, F.Braga, T.Roraas,. A systematic review of data on biological variation for alanine aminotransferase, aspartate aminotransferase and γ-glutamyl transferase. Clin Chem Lab Med 2013;51:1997–2007
24. W.A.Bartlett, F.Braga, A.Carobene,. A checklist for critical appraisal of studies of biological variation. Clin Chem Lab Med 2015;53:879–85
25. STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies. Available from: http://www.stard-statement.org. [last accessed 16 Jan 2016]
26. C.1.Ricós, N.Iglesias, J.V.García-Lario,. Within-subject biological variation in disease: collated data and clinical consequences. Ann Clin Biochem 2007;44:343–52
27. N.Lawson Is variation in biological variation a problem? Ann Clin Biochem 2007;44:319–20
28. C.G.Fraser Improved monitoring of differences in serial laboratory results. Clin Chem 2011;57:1635–7
29. C.Fraser, S.T.Cummings, S.P.Wilkinson,. Biological variability of 26 clinical chemistry analytes in elderly people. Clin Chem 1989;35:783–6
30. A.Carobene, M.S.Graziani, C.Lo Cascio,. Age dependence of within-subject biological variation of nine common clinical chemistry analytes. Clin Chem Lab Med 2012;50:841–4
31. F.Braga, S.Ferraro, R.Mozzi,. The importance of individual biology in the clinical use of serum biomarkers for ovarian cancer. Clin Chem Lab Med 2014;52:1625–31
32. E.M.Gowans, C.G.Fraser Longer-term biological variation of commonly analyzed serum constituents. Clin Chem 1987;33:717
33. G.Lippi, C.Mattiuzzi, G.Banfi Proposta di una “checklist” per il prelievo di sangue venoso. Biochim Clin 2013;37:312–17
34. G.Lippi, M.Caputo, G.Banfi,. Giavarina D per il Gruppo di Studio Intersocietario SIBioC-SIMeL-CISMEL sulla Variabilità Extra-Analitica del Dato di Laboratorio. Raccomandazioni per il prelievo di sangue venoso. Biochim Clin 2008;32:569–77
35. M.Panteghini, F.Pagani On the comparison of serum and plasma samples in troponin assays. Clin Chem 2003;49:835–6
36. G.R.D.Jones, M.Panteghini Pre-analytical factors affecting troponin measurement. In: J.Tate, R.Johnson, A.Jaffe, M.Panteghini, ed. Laboratory and Clinical Issues Affecting the Measurement and Reporting of Cardiac Troponin: A Guide for Clinical Laboratories. Alexandria, NSW, Australia: The Australasian Association of Clinical Biochemists, 2012:63–7
37. F.Braga, S.Ferraro, R.Mozzi,. Biological variation of neuroendocrine tumor markers chromogranin A and neuron-specific enolase. Clin Biochem 2013;46:148–51
38. M.Panteghini, F.Pagani Biological variation in bone-derived biochemical markers in serum. Scand J Clin Lab Invest 1995;55:609–16
39. F.Pagani, M.Panteghini Significance of various parameters derived from biological variability for lipid and lipoprotein analyses. Clin Biochem 1993;26:415–20
40. A.H.Garde, A.M.Hansen, L.T.Skovgaard,. Seasonal and biological variation of blood concentrations of total cholesterol, dehydroepiandrosterone sulfate, hemoglobin A1c, IgA, prolactin, and free testosterone in healthy women. Clin Chem 2000;46:551–9
41. M.Panteghini Traceability, reference systems and result comparability. Clin Biochem Rev 2007;28:97–104
42. F.Braga, M.Panteghini Standardization and analytical goals for glycated hemoglobin measurement. Clin Chem Lab Med 2013;51:1719–26
43. F.Braga, A.Dolci, M.Montagnana,. Revaluation of biological variation of glycated hemoglobin (HbA1c) using an accurately designed protocol and an assay traceable to the IFCC reference system. Clin Chim Acta 2011;412:1412–16
44. A.Carobene, F.Ceriotti, I.Infusino,. Evaluation of the impact of standardization process on the quality of serum creatinine determination in Italian laboratories. Clin Clin Acta 2014;427:100–6
45. M.Panteghini Enzymatic assays for creatinine: time for action. Clin Chem Lab Med 2008;46:567–72
46. M.Panteghini Quality requirements for troponin assays – An overview. In: Troponin Monograph 2012. Alexandria, NSW, Australia: The Australasian Association of Clinical Biochemists Inc., 2012:53–61
47. V.C.Vasile, A.K.Saenger, J.M.Kroning,. Procalcitonin in healthy individuals. Electronic letter to Barassi A, Pallotti F, d Eril GM. Biological variation of procalcitonin in healthy individuals. Clin Chem 2004;50:1086. Available at: http://www.zoominfo.com/CachedPage/?archive_id=0&page_id=857341327&page_url=//www.clinchem.org/cgi/eletters/50/10/1878&page_last_updated=2004-10-11T03:42:47&firstName=Nils&lastName=Morgenthaler
48. L.Frankenstein, A.H.Wu, K.Hallermayer,. Biological variation and reference change value of high-sensitivity troponin T in healthy individuals during short and intermediate follow-up periods. Clin Chem 2011;57:1068–71
49. G.M.Nils, J.Struck, A.Bergmann Procalcitonin in healthy individuals. Electronic letter to Barassi A, Pallotti F, d'Eril GM. Biological variation of procalcitonin in healthy individuals. Clin Chem 2004;50:1878.Available at: http://www.zoominfo.com/CachedPage/?archive_id=0&page_id=857341327&page_url=//www.clinchem.org/cgi/eletters/50/10/1878&page_last_updated=2004-10-11T03:42:47&firstName=Nils&lastName=Morgenthaler
50. D.S.Young, E.K.Harris, E.Cotlove Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. IV. Results of a study designed to eliminate long-term analytic deviations. Clin Chem 1971;17:403–10
51. F.Braga, I.Infusino, M.Panteghini Performance criteria for combined uncertainty budget in the implementation of metrological traceability. Clin Chem Lab Med 2015;53:905–12
52. S.S.Shapiro, M.B.Wilk An analysis of variance test for normality (complete samples). Biometrika 1965;52:591–611
53. W.W.Daniel Kolmogorov–Smirnov one-sample test. In: W.W.Daniel, ed. Applied Nonparametric Statistics. 2nd ed. Boston (MA): Cengage, 1990:319–30
54. M.P.Fay, M.A.Proschan Wilcoxon–Mann–Whitney or t-test? On assumptions for hypothesis tests and multiple interpretations of decision rules. Stat Surv 2010;4:1–39. doi: 10.1214/09-SS051
55. G.W.Snedecor, W.G.Cochran Statistical Methods. 8th ed. Iowa State University Press, 1989
56. W.G.Cochran The distribution of the largest of a set of estimated variances as a fraction of their total. Ann Hum Genet 1941;11:47–52
57. H.Levene Robust tests for equality of variances In: I.Olkin , eds. Contributions to Probability and Statistics: Essays in Honor of Harold Hotelling. Stanford University Press, 1960;278–92
58. M.B.Brown, A.B.Forsythe Robust tests for equality of variances. J Amer Statist Assoc 1974;69:364–7
59. W.J.Conover, M.E.Johnson, M.M.Johnson A comparative study of tests for homogeneity of variances, with applications to the outer continental shelf bidding data. Technometrics 1981;23:351–61
60. T.Roraas, P.H.Petersen, S.Sandberg Confidence intervals and power calculations for within-subject biological variation: effect of analytical variation, number of replicates, number of samples and number of individuals. Clin Chem 2012;58:1306–13
61. A.M.Simundic, S.Kackov, M.Miler,. Terms and symbols used on studies of biological variation: the need for harmonisation. Clin Chem 2015;61:438–9
62. C.Perich, J.Minchinela, C.Ricós,. Biological variation database: structure and criteria used for generation and update. Clin Chem Lab Med 2015;53:299–305
63. E.Topic, N.Nikolac, M.Panteghini,. How to assess the quality of your analytical method? Clin Chem Lab Med 2015;53:1707–18
64. E.M.DeGoma, B.French, R.L.Dunbar,. Intraindividual variability of C- reactive protein: the multi-ethnic study of atherosclerosis. Atherosclerosis 2012;224:274–9
65. R.D.J.Glynn, J.G.MacFadyen, P.M.Ridker Tracking of high-sensitivity C-reactive protein after an initially elevated concentration: the JUPITER Study. Clin Chem 2009;55:305–12
66. B.Campbell, T.Badrick, R.Flatman,. Limited clinical utility of high-sensitivity plasma C-reactive protein assays. Ann Clin Biochem 2002;39:85–8
67. S.Ferraro, F.Braga, M.Lanzoni,. Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review. J Clin Pathol 2013;66:273–81
68. S.Ferraro, D.Schiumarini, M.Panteghini Human epididymis protein 4: factors of variation. Clin Chim Acta 2015;438:171–7
69. E.Anastasi, T.Granato, G.G.Marchei,. Ovarian tumor marker HE4 is differently expressed during the phase of menstrual cycle in healthy young women. Tumor Biol 2010;31:411–15
70. S.Ferraro, S.Borille, S.Caruso,. Body mass index does not influence human hepididymis protein 4 concentrations in serum. Clin Chim Acta 2015;446:163–4
71. P.M.Ridker, N.Rifai. C-reactive protein in the primary prevention of myocardial infarction and stroke. In: P.M.Ridker, N.Rifai eds. C-reactive protein and cardiovascular disease. St-Laurent (QC): MediEdition, 2006:1–23
72. D.E.Chiriboga, Y.Ma, W.Li,. Seasonal and sex variation of high-sensitivity C reactive protein in healthy adults: a longitudinal study. Clin Chem 2009;55:313–21
73. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33:S62–9
74. W.Hoelzel, K.Miedema Development of a reference system for the international standardization of HbA1c/glycohemoglobin determinations. J Int Fed Clin Chem 1996;9:62–7
75. C.Weykamp, W.G.John, A.Mosca,. The IFCC reference measurement system for HbA1c: a 6-year progress report. Clin Chem 2008;54:240–8
76. R.R.Little, C.L.Rohlfing, D.B.Sacks Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care. Clin Chem 2011;57:205–14
77. M.Panteghini, W.G.John Implementation of haemoglobin A1c results traceable to the IFCC reference system: the way forward. Clin Chem Lab Med 2007;45:942–4
78. W.Hoelzel, C.Weykamp, J.Jeppsson,. Wiedmeyer HM on behalf of the IFCC Working Group on HbA1c Standardization IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 2004;50:166–74
79. C.W.Weykamp, A.Mosca, P.Gillery,. The analytical goals for hemoglobin A1c measurement in IFCC units and National Glycohemoglobin Standardization Program units are different. Clin Chem 2011;57:1204–6
80. F.Braga, I.Infusino, A.Dolci,. Biological variation of free light chains in serum. Clin Chim Acta 2013;415:10–11
81. R.U.’t Lam Scrutiny of variance results for outliers: Cochran’s test optimized. Anal Chim Acta 2010;659:68–84
82. F.Braga, D.Szőke, C.Valente,. Biologic variation of copper, ceruloplasmin and copper/ceruloplasmin ratio (Cu:Cp) in serum. Clin Chim Acta 2013;415:295–6